BR112014026086A2 - aplicação de 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas na terapia da menorragia, bem como sistemas intrauterinos contendo 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas para a terapia de distúrbios de sangramento uterino - Google Patents

aplicação de 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas na terapia da menorragia, bem como sistemas intrauterinos contendo 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas para a terapia de distúrbios de sangramento uterino

Info

Publication number
BR112014026086A2
BR112014026086A2 BR112014026086A BR112014026086A BR112014026086A2 BR 112014026086 A2 BR112014026086 A2 BR 112014026086A2 BR 112014026086 A BR112014026086 A BR 112014026086A BR 112014026086 A BR112014026086 A BR 112014026086A BR 112014026086 A2 BR112014026086 A2 BR 112014026086A2
Authority
BR
Brazil
Prior art keywords
spirox
methylen
therapy
methyl
15beta
Prior art date
Application number
BR112014026086A
Other languages
English (en)
Inventor
Jukarainen Harri
Korolainen Henriikka
Prelle Katja
Röse Lars
Schmees Norbert
Nubbemeyer Reinhard
Valo Tuula
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48141995&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014026086(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of BR112014026086A2 publication Critical patent/BR112014026086A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

resumo patente de invenção: "aplicação de 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas na terapia da menorragia, bem como sistemas intrauterinos contendo 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas para a terapia de distúrbios de sangramento uterino". a presente invenção refere-se a descrição da aplicação intrauterina de 18-metil-15ß,16ß-metilen-19-nor-20-spirox-4-en-3-ona da fórmula geral (i), (1) na qual r6 e r7 representam hidrogênio ou um grupo metileno, na terapia da menorragia, de modo geral de sangramentos uterinos, bem como um sistema intrauterino para a aplicação mencionada contendo um composto da fórmula (i).
BR112014026086A 2012-04-23 2013-04-19 aplicação de 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas na terapia da menorragia, bem como sistemas intrauterinos contendo 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas para a terapia de distúrbios de sangramento uterino BR112014026086A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012206653 2012-04-23
PCT/EP2013/058152 WO2013160200A1 (de) 2012-04-23 2013-04-19 ANWENDUNG VON 18-METHYL-15ß,16ß-METHYLEN-19-NOR-20-SPIROX-4-EN-3-ONEN BEI DER THERAPIE DER MENORRHAGIA, SOWIE 18-METHYL-15ß,16ß-METHYLEN-19-NOR-20-SPIROX-4-EN-3-ONE ENTHALTENDE INTRAUTERINE SYSTEME FÜR DIE THERAPIE UTERINEN BLUTUNGSSTÖRUNGEN

Publications (1)

Publication Number Publication Date
BR112014026086A2 true BR112014026086A2 (pt) 2017-07-18

Family

ID=48141995

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014026086A BR112014026086A2 (pt) 2012-04-23 2013-04-19 aplicação de 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas na terapia da menorragia, bem como sistemas intrauterinos contendo 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas para a terapia de distúrbios de sangramento uterino

Country Status (28)

Country Link
US (1) US20150119372A1 (pt)
EP (1) EP2841073A1 (pt)
JP (1) JP2015514789A (pt)
KR (1) KR20150005548A (pt)
CN (1) CN104379149A (pt)
AR (1) AR090800A1 (pt)
AU (1) AU2013251842A1 (pt)
BR (1) BR112014026086A2 (pt)
CA (1) CA2871001A1 (pt)
CL (1) CL2014002857A1 (pt)
CO (1) CO7111253A2 (pt)
CR (1) CR20140489A (pt)
CU (1) CU20140120A7 (pt)
DO (1) DOP2014000240A (pt)
EA (1) EA201491917A1 (pt)
EC (1) ECSP14024263A (pt)
GT (1) GT201400225A (pt)
HK (1) HK1206271A1 (pt)
IL (1) IL235096A0 (pt)
MA (1) MA37443A1 (pt)
MX (1) MX2014012848A (pt)
PE (1) PE20142437A1 (pt)
PH (1) PH12014502371A1 (pt)
SG (1) SG11201406583QA (pt)
TN (1) TN2014000445A1 (pt)
TW (1) TW201345530A (pt)
UY (1) UY34759A (pt)
WO (1) WO2013160200A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90627C (fi) 1992-07-31 1994-03-10 Leiras Oy Laitteisto lääkeainesauvan varustamiseksi vaipalla
PH30867A (en) 1992-07-31 1997-12-09 Leiras Oy Method and equipment for installing a medicine capsule on a support.
FI107339B (fi) 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
DE102006030416A1 (de) * 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
US20150119372A1 (en) 2015-04-30
CR20140489A (es) 2014-12-24
UY34759A (es) 2013-11-29
WO2013160200A1 (de) 2013-10-31
PE20142437A1 (es) 2015-01-31
CA2871001A1 (en) 2013-10-31
AR090800A1 (es) 2014-12-10
CU20140120A7 (es) 2015-02-26
DOP2014000240A (es) 2015-02-15
TN2014000445A1 (en) 2016-03-30
AU2013251842A1 (en) 2014-11-06
MA37443A1 (fr) 2016-05-31
PH12014502371A1 (en) 2015-01-12
MX2014012848A (es) 2015-02-05
CL2014002857A1 (es) 2015-02-06
ECSP14024263A (es) 2015-12-31
TW201345530A (zh) 2013-11-16
SG11201406583QA (en) 2014-11-27
GT201400225A (es) 2016-01-22
CO7111253A2 (es) 2014-11-10
CN104379149A (zh) 2015-02-25
IL235096A0 (en) 2014-12-31
EP2841073A1 (de) 2015-03-04
KR20150005548A (ko) 2015-01-14
JP2015514789A (ja) 2015-05-21
HK1206271A1 (en) 2016-01-08
EA201491917A1 (ru) 2015-04-30

Similar Documents

Publication Publication Date Title
BR112014026703A2 (pt) inibidores de dna-pk
EA201590586A1 (ru) Терапевтические наночастицы, включающие терапевтический агент, способы их получения и применения
BR112013028449A2 (pt) composições compreendendo partículas de hidrogel
BR112016013299A2 (pt) Composto
BR112015002118A2 (pt) 4-metil-2,3,5,9,9b-pentaaza-ciclopenta[a]naftalenos
CR20140397A (es) Compuestos de oxazolidin-2-ona y usos de los mismos como inhibidores de la pi3ks
BR112015022047A2 (pt) métodos para tratar câncer de bexiga
BR112013023876A2 (pt) derivados de pirroltriazinona como inibidores de pi3k
BR112013028907A2 (pt) conjugados de proteína-agente ativo e método para preparar os mesmos
BR112014001600A2 (pt) composto inibidor do trajeto de sinalização notch
BR112015000561A2 (pt) inibidores de irak e usos dos mesmos
BR112014028991A2 (pt) triazóis como inibidores de kv3
BR112013025732A2 (pt) composto de imidazo-oxazina ou sal do mesmo
MX2019001093A (es) Profarmacos de metilfenidato, procesos de elaboracion y uso de los mismos.
BR112014027303A2 (pt) identificação de variantes de isopreno sintase com propriedades optimizadas para a produção de isopreno
BR112015029504A2 (pt) inibidores quinase
BR112014012459A2 (pt) 2h-indazóis como antagonistas do receptor de ep2
BR112015018047A2 (pt) composições estáveis que compreendem heparinoide, anestésico de ação aguda e tampão
BR112012025331A2 (pt) "fertilização in vitro facilitada pelo perfil do secretoma"
BR112014017902A2 (pt) Agente terapêutico ou profilático para doenças causadas por distúrbios do metabolismo de glicose
BR112015001859A2 (pt) tratamento de inflamação utilizando serelaxina
BR112015029619A2 (pt) derivados de 1,3-diaminociclopentano carboxamida
BR112014000889A2 (pt) tratamento para hipoxia
BR112013028607A2 (pt) composições sólidas contendo éter glicólico e água
BR112015015373A2 (pt) métodos de integração da produção de aluminoxano na produçâo de catalisador

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]